FDA Approves Sotorasib / Lumakras + Panitumumab / Vectibix for KRAS G12C Mutation Extending Survival Colorectal 3 Mins Read On January 16, 2025, a significant advancement in cancer treatment was announced. The FDA approved a new therapeutic option for…
